PL2857039T3 - Środek terapeutyczny lub środek profilaktyczny na otępienie - Google Patents
Środek terapeutyczny lub środek profilaktyczny na otępienieInfo
- Publication number
- PL2857039T3 PL2857039T3 PL13797290T PL13797290T PL2857039T3 PL 2857039 T3 PL2857039 T3 PL 2857039T3 PL 13797290 T PL13797290 T PL 13797290T PL 13797290 T PL13797290 T PL 13797290T PL 2857039 T3 PL2857039 T3 PL 2857039T3
- Authority
- PL
- Poland
- Prior art keywords
- agent
- dementia
- prophylactic
- therapeutic agent
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012124336 | 2012-05-31 | ||
| PCT/JP2013/065090 WO2013180238A1 (ja) | 2012-05-31 | 2013-05-30 | 認知症治療剤又は予防剤 |
| EP13797290.7A EP2857039B1 (en) | 2012-05-31 | 2013-05-30 | Therapeutic agent or prophylactic agent for dementia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2857039T3 true PL2857039T3 (pl) | 2020-05-18 |
Family
ID=49673425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13797290T PL2857039T3 (pl) | 2012-05-31 | 2013-05-30 | Środek terapeutyczny lub środek profilaktyczny na otępienie |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US20150183854A1 (pl) |
| EP (2) | EP3662931B1 (pl) |
| JP (3) | JP5971659B2 (pl) |
| KR (2) | KR102133610B1 (pl) |
| CN (1) | CN104602708B (pl) |
| AR (1) | AR091218A1 (pl) |
| AU (2) | AU2013268364B2 (pl) |
| BR (1) | BR112014029566A2 (pl) |
| CA (1) | CA2875205C (pl) |
| CY (1) | CY1122530T1 (pl) |
| DK (1) | DK2857039T3 (pl) |
| ES (1) | ES2763361T3 (pl) |
| HK (1) | HK1210031A1 (pl) |
| HR (1) | HRP20192267T1 (pl) |
| HU (1) | HUE046919T2 (pl) |
| IL (1) | IL235899B (pl) |
| LT (1) | LT2857039T (pl) |
| ME (1) | ME03587B (pl) |
| MX (1) | MX361128B (pl) |
| MY (1) | MY172458A (pl) |
| NZ (1) | NZ630536A (pl) |
| PH (1) | PH12014502669B1 (pl) |
| PL (1) | PL2857039T3 (pl) |
| PT (1) | PT2857039T (pl) |
| RS (1) | RS59802B1 (pl) |
| RU (1) | RU2657438C2 (pl) |
| SG (2) | SG10201805410XA (pl) |
| SI (1) | SI2857039T1 (pl) |
| TW (2) | TWI777183B (pl) |
| WO (1) | WO2013180238A1 (pl) |
| ZA (1) | ZA201409186B (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2670434B1 (en) | 2011-01-31 | 2018-12-26 | Tau Bio-Logic Corp. | Treatment of tauopathies |
| WO2012162179A1 (en) * | 2011-05-20 | 2012-11-29 | Oligomerix, Inc. | Tau protease compositions and methods of use |
| HUE046919T2 (hu) * | 2012-05-31 | 2020-04-28 | Univ Osaka City | Terápiás szer vagy profilaktikus szer demenciára |
| WO2014008404A1 (en) | 2012-07-03 | 2014-01-09 | Washington University | Antibodies to tau |
| TW202136296A (zh) | 2014-06-27 | 2021-10-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗-tau抗體 |
| EP3448875A4 (en) * | 2016-04-29 | 2020-04-08 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| JP6785372B2 (ja) * | 2016-09-30 | 2020-11-18 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 多重特異性分子の機能分析のためのｓｐｒに基づく二重結合アッセイ |
| MX2019009817A (es) | 2017-02-17 | 2019-11-21 | Denali Therapeutics Inc | Anticuerpos anti-tau y metodos de uso de los mismos. |
| JP2018139530A (ja) | 2017-02-27 | 2018-09-13 | 帝人ファーマ株式会社 | 認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤 |
| IL270971B1 (en) | 2017-05-30 | 2024-02-01 | Teijin Pharma Ltd | Antibody against the 1-IGF receptor |
| WO2019070492A1 (en) | 2017-10-02 | 2019-04-11 | Merck Sharp & Dohme Corp. | CHROMANE MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS |
| CA3077247A1 (en) | 2017-10-16 | 2019-04-25 | Eisai R & D Management Co., Ltd. | Anti-tau antibodies and uses thereof |
| WO2019194314A1 (ja) | 2018-04-06 | 2019-10-10 | 帝人ファーマ株式会社 | Ｓｐｎｓ２中和抗体 |
| JP7340794B2 (ja) * | 2018-07-04 | 2023-09-08 | 学校法人 愛知医科大学 | タウのスプライシングを制御するアンチセンスオリゴヌクレオチド及びその用途 |
| CN110028583B (zh) * | 2019-05-07 | 2020-09-11 | 温州医科大学 | 抗Tau抗体及其在治疗阿尔茨海默病、创伤性脑损伤中的应用 |
| JP7429404B2 (ja) * | 2019-08-06 | 2024-02-08 | 慶應義塾 | タウ関連疾患モデルの製造方法 |
| US20220365102A1 (en) | 2019-09-30 | 2022-11-17 | Nipro Corporation | Tau protein detection method using blood sample as test specimen |
| JP2023518281A (ja) * | 2020-03-19 | 2023-04-28 | ヴァスキュラー バイオサイエンスィズ | コロナウイルス生存率改善のためのｃａｒペプチド |
| CA3183835A1 (en) | 2020-06-25 | 2021-12-30 | Jeanne E. Baker | High affinity antibodies targeting tau phosphorylated at serine 413 |
| WO2023092004A1 (en) | 2021-11-17 | 2023-05-25 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of tau-related disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS587390B2 (ja) | 1975-03-11 | 1983-02-09 | ツキシマキカイ カブシキガイシヤ | ア−クヨウセツホウホウ |
| JP3587390B2 (ja) | 1994-03-17 | 2004-11-10 | タカラバイオ株式会社 | リン酸化アミノ酸誘導体及びリン酸化ペプチド合成方法 |
| US20020086009A1 (en) * | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| US20080199471A1 (en) * | 2002-03-01 | 2008-08-21 | Bernett Matthew J | Optimized cd40 antibodies and methods of using the same |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| US20070280935A1 (en) * | 2006-04-07 | 2007-12-06 | Bernd Bohrmann | Antibody that recognizes phosphorylated peptides |
| KR20090019864A (ko) * | 2006-06-16 | 2009-02-25 | 엔비보 파마슈티칼즈, 인코퍼레이티드 | Ｔａｕ와 아밀로이드 전구체 단편을 발현하는 유전자도입 파리 |
| UA107571C2 (xx) * | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| EA032675B1 (ru) * | 2009-06-10 | 2019-07-31 | Нью-Йорк Юниверсити | Способ и композиции для лечения болезни альцгеймера и других таупатий |
| EP2670434B1 (en) * | 2011-01-31 | 2018-12-26 | Tau Bio-Logic Corp. | Treatment of tauopathies |
| TR201102696U (tr) * | 2011-05-27 | 2011-06-21 | Turhal Sal�H | Bağlantısız hareketli ürün reklam standı. |
| HUE046919T2 (hu) * | 2012-05-31 | 2020-04-28 | Univ Osaka City | Terápiás szer vagy profilaktikus szer demenciára |
-
2013
- 2013-05-30 HU HUE13797290A patent/HUE046919T2/hu unknown
- 2013-05-30 TW TW109121902A patent/TWI777183B/zh active
- 2013-05-30 SG SG10201805410XA patent/SG10201805410XA/en unknown
- 2013-05-30 KR KR1020147035417A patent/KR102133610B1/ko active IP Right Grant
- 2013-05-30 PL PL13797290T patent/PL2857039T3/pl unknown
- 2013-05-30 RS RS20191640A patent/RS59802B1/sr unknown
- 2013-05-30 CN CN201380040658.9A patent/CN104602708B/zh active Active
- 2013-05-30 EP EP19207405.2A patent/EP3662931B1/en active Active
- 2013-05-30 DK DK13797290.7T patent/DK2857039T3/da active
- 2013-05-30 EP EP13797290.7A patent/EP2857039B1/en active Active
- 2013-05-30 SI SI201331636T patent/SI2857039T1/sl unknown
- 2013-05-30 NZ NZ630536A patent/NZ630536A/en unknown
- 2013-05-30 AR ARP130101907 patent/AR091218A1/es active IP Right Grant
- 2013-05-30 SG SG11201407878VA patent/SG11201407878VA/en unknown
- 2013-05-30 KR KR1020207007010A patent/KR102208283B1/ko active IP Right Grant
- 2013-05-30 MY MYPI2014703534A patent/MY172458A/en unknown
- 2013-05-30 ES ES13797290T patent/ES2763361T3/es active Active
- 2013-05-30 RU RU2014153099A patent/RU2657438C2/ru active
- 2013-05-30 AU AU2013268364A patent/AU2013268364B2/en active Active
- 2013-05-30 MX MX2014014187A patent/MX361128B/es active IP Right Grant
- 2013-05-30 US US14/403,803 patent/US20150183854A1/en not_active Abandoned
- 2013-05-30 BR BR112014029566A patent/BR112014029566A2/pt not_active Application Discontinuation
- 2013-05-30 LT LTEP13797290.7T patent/LT2857039T/lt unknown
- 2013-05-30 CA CA2875205A patent/CA2875205C/en active Active
- 2013-05-30 WO PCT/JP2013/065090 patent/WO2013180238A1/ja active Application Filing
- 2013-05-30 ME MEP-2019-341A patent/ME03587B/me unknown
- 2013-05-30 TW TW102119176A patent/TWI700296B/zh active
- 2013-05-30 PT PT137972907T patent/PT2857039T/pt unknown
- 2013-05-30 JP JP2014518734A patent/JP5971659B2/ja active Active
-
2014
- 2014-11-25 IL IL235899A patent/IL235899B/en active IP Right Grant
- 2014-11-28 PH PH12014502669A patent/PH12014502669B1/en unknown
- 2014-12-12 ZA ZA2014/09186A patent/ZA201409186B/en unknown
-
2015
- 2015-11-03 HK HK15110820.8A patent/HK1210031A1/xx unknown
-
2016
- 2016-05-09 JP JP2016094112A patent/JP6406678B2/ja active Active
-
2018
- 2018-01-18 AU AU2018200413A patent/AU2018200413B2/en active Active
- 2018-03-19 JP JP2018051046A patent/JP6620829B2/ja active Active
-
2019
- 2019-06-10 US US16/436,301 patent/US20200148753A1/en not_active Abandoned
- 2019-12-13 CY CY20191101311T patent/CY1122530T1/el unknown
- 2019-12-17 HR HRP20192267TT patent/HRP20192267T1/hr unknown
-
2021
- 2021-12-01 US US17/539,926 patent/US20220340646A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1210031A1 (en) | Therapeutic agent or prophylactic agent for dementia | |
| HK1211475A1 (en) | Combination therapy | |
| PL3153144T3 (pl) | Urządzenie izolacyjne | |
| SG11201501173SA (en) | PI3Kδ INHIBITOR | |
| HK1216297A1 (zh) | 腫瘤溶解綜合征的治療藥和預防藥 | |
| HK1208628A1 (en) | Prophylactic or therapeutic agent for hepatic diseases | |
| EP2823830A4 (en) | MESH-HIGHNESS MEDIUM | |
| EP2671585A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGGREGATE AGAINST CACHEXIA | |
| SG11201500074XA (en) | Safety cabinet | |
| GB201217439D0 (en) | Combination therapy | |
| EP2925877A4 (en) | milling | |
| EP2925876A4 (en) | milling | |
| EP2554541A4 (en) | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR FIBROMYALGIA | |
| IL236450A (en) | Process for making 5-fluoro-h1-pyrazoles | |
| PL399418A1 (pl) | Sposób wytwarzania 4-metoksydihydrochalkonu | |
| PL399419A1 (pl) | Sposób wytwarzania 4-metoksydihydrochalkonu | |
| GB201207305D0 (en) | Therapy | |
| PL2677104T3 (pl) | Szafka bezpieczeństwa | |
| HK1210426A1 (en) | Combination therapy | |
| EP2925790A4 (en) | milling | |
| EP2914267A4 (en) | TREATMENT OF DARM CONSTIPATION | |
| GB2502527B (en) | Plumbing apparatus | |
| GB201214234D0 (en) | Prophylactic therapy | |
| GB201220253D0 (en) | Plumbing apparatus | |
| PL2861904T3 (pl) | Ulepszone urządzenie instalacji wodociągowej |